AI ENRICH - AI Detection of ICH
| Status: | Recruiting |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/27/2019 |
| Start Date: | March 22, 2019 |
| End Date: | March 2020 |
| Contact: | Derick En'Wezoh, MD |
| Email: | derick@viz.ai |
| Phone: | 5094307410 |
Automated Detection, Characterization, Triage, and Recruitment of ICH Subjects Using Artificial Intelligence in the ENRICH Trial
To evaluate the performance of the Viz RECRUIT software in subjects identified as symptomatic
of a stroke event as determined by standard of care imaging assessments and interpretation.
of a stroke event as determined by standard of care imaging assessments and interpretation.
This study will be a multicenter prospective feasibility trial to evaluate the performance of
the Viz RECRUIT software. This study will enroll subjects evaluated at each center for stroke
via CT imaging. The Viz RECRUIT software will review the CT and notify a specialist if an ICH
is detected. It will also evaluate the ICH parameters per study specific guidelines related
to the ENRICH Trial and notify a specialist if their ICH meets the study inclusion or
exclusion criteria related to cerebral blood flow volume. If an enrolled subject is
ultimately included in the ENRICH trial, they will be identified in a prospective cohort of
subjects exposed to Viz (intervention arm) will be evaluated per the secondary endpoints to a
cohort of subjects retrospectively from the ENRICH Trial (control arm) which were evaluated
and enrolled prior to Viz use.
the Viz RECRUIT software. This study will enroll subjects evaluated at each center for stroke
via CT imaging. The Viz RECRUIT software will review the CT and notify a specialist if an ICH
is detected. It will also evaluate the ICH parameters per study specific guidelines related
to the ENRICH Trial and notify a specialist if their ICH meets the study inclusion or
exclusion criteria related to cerebral blood flow volume. If an enrolled subject is
ultimately included in the ENRICH trial, they will be identified in a prospective cohort of
subjects exposed to Viz (intervention arm) will be evaluated per the secondary endpoints to a
cohort of subjects retrospectively from the ENRICH Trial (control arm) which were evaluated
and enrolled prior to Viz use.
Inclusion Criteria:
- Subjects with stroke symptoms who undergo CT brain imaging.
Exclusion Criteria:
- Subjects with poor or incomplete CT brain imaging.
We found this trial at
1
site
1364 Clifton Rd NE
Atlanta, Georgia 30322
Atlanta, Georgia 30322
(404) 712-2000
Principal Investigator: Gustavo Pradilla, MD
Phone: 404-778-1845
Emory University Hospital As the largest health care system in Georgia and the only health...
Click here to add this to my saved trials
